Clinical Trials on Myelodysplastic Syndrome in Canada
Total 2049 results
-
Sunnybrook Health Sciences CentreNovartisTerminatedMyelodysplastic SyndromesCanada
-
McMaster UniversityCBSRecruitingMyelodysplastic SyndromeCanada
-
National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic SyndromesCanada, United States
-
Sunnybrook Health Sciences CentreNot yet recruitingMyelodysplastic Syndromes | MDSCanada
-
Sunnybrook Health Sciences CentreCelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myelomonocytic, Chronic | AngiogenesisCanada
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndromes (MDS)United States, Australia, Canada, France, Germany, Italy, United Kingdom
-
Asociación Andaluza de Hematología y HemoterapiaCompleted
-
Sunnybrook Health Sciences CentreHealth Sciences Centre, Winnipeg, Manitoba; The Ottawa Hospital; Jewish General... and other collaboratorsUnknownMyelodysplastic Syndrome (MDS)Canada
-
Sunnybrook Health Sciences CentrePrincess Margaret Hospital, Canada; Juravinski Cancer CenterUnknownQuality of Life | Myelodysplastic Syndromes (MDS) | Red Blood Cell (RBC) TransfusionsCanada
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); Canadian Blood ServicesTerminatedLeukemia | Myelodysplastic SyndromeCanada
-
University Health Network, TorontoCompletedMyelodysplastic/Myeloproliferative Neoplasm | Allogeneic Hematopoietic Cell Transplant | Steroid Refractory GVHDCanada
-
Ottawa Hospital Research InstituteSuspendedAcute Leukemia | Myelodysplastic SyndromeCanada
-
Mirati Therapeutics Inc.CompletedMyelodysplastic Syndromes | LeukemiaCanada, United States
-
Sunnybrook Health Sciences CentreQueen's University; Ontario Molecular Pathology Research NetworkUnknownCardiovascular Diseases | Inflammation | MDSCanada
-
Mirati Therapeutics Inc.CompletedMyelodysplastic Syndromes | LeukemiaUnited States, Canada
-
Novartis PharmaceuticalsCompletedLow and Int 1-risk Myelodysplastic SyndromeGermany, Canada, Korea, Republic of, Sweden, Spain, China, Argentina, Italy, United Kingdom, Algeria
-
Hoffmann-La RocheTerminatedMyelodysplastic Syndromes, Myelogenous Leukemia, AcuteUnited States, Canada, Germany
-
Mirati Therapeutics Inc.TerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States, Canada, United Kingdom
-
Astex Pharmaceuticals, Inc.CompletedMyelodysplastic Syndrome | MDSUnited States, Canada
-
PETHEMA FoundationCompletedMyelodysplastic SyndromeSpain
-
Gemin XCompletedMyelodysplastic SyndromesCanada, United States
-
Nova Scotia Health AuthorityTerry Fox Research InstituteCompletedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)Canada
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndrome (MDS)United States, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Secondary Acute Myeloid Leukemia and other conditionsCanada
-
Astex Pharmaceuticals, Inc.Active, not recruitingMyelodysplastic SyndromesSpain, United States, Belgium, Canada, Germany, Italy
-
Eisai Inc.CompletedMyelodysplastic SyndromeUnited States, Canada
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, United Kingdom, Australia, Poland, Spain, Belgium, Italy, Germany, France, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Myelodysplastic/Myeloproliferative NeoplasmsUnited States, Canada, Australia, Puerto Rico
-
Genzyme, a Sanofi CompanyCompletedMyelodysplastic SyndromesUnited States, Canada
-
CASI Pharmaceuticals, Inc.CompletedMyelodysplasia | Hematological Malignancies | Agnogenic Myeloid MetaplasiaCanada
-
Ciusss de L'Est de l'Île de MontréalExCellThera inc.; Stem Cell NetworkActive, not recruitingCord Blood Transplant | High Risk Hematologic MalignancyCanada
-
Novartis PharmaceuticalsTerminatedThrombocytopaeniaUnited States, Belgium, Australia, Canada, Hong Kong, Austria, Brazil, Czechia, Israel, Russian Federation, Spain, Sweden, Thailand, Denmark, France, Germany, Ireland, Italy, Korea, Republic of, Peru, Switzerland, Taiwan, Turkey, Hungary and more
-
NCIC Clinical Trials GroupBayerCompletedMyelodysplastic Syndromes | LeukemiaCanada
-
University Health Network, TorontoActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Relapsed Cancer | Refractory CancerCanada
-
Vor BiopharmaRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Canada
-
Novartis PharmaceuticalsActive, not recruitingMyelodysplastic SyndromesCzechia, Hungary, Japan, Taiwan, United States, Belgium, Italy, United Kingdom, Korea, Republic of, Hong Kong, Austria, Germany, Turkey, Spain, Greece, France, Canada
-
Astex Pharmaceuticals, Inc.CompletedAML | MDS | CMMLUnited States, Canada
-
CelgeneAcceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme...CompletedMyelodysplastic SyndromesCanada, United States, Germany, Belgium, France, United Kingdom, Turkey, Spain, Italy, Netherlands, Sweden
-
Bristol-Myers SquibbRecruitingMyelodysplastic SyndromesUnited States, Japan, Argentina, Hong Kong, Greece, Italy, China, Australia, Spain, Austria, Denmark, Germany, Sweden, Switzerland, Canada, Czechia, Korea, Republic of, Poland, Turkey, France
-
Geron CorporationActive, not recruitingMyelodysplastic SyndromesUnited States, Canada, Belgium, Spain, Czechia, Korea, Republic of, United Kingdom, Netherlands, Israel, Germany, Russian Federation, Switzerland, Italy, France, Turkey, Poland, Ukraine
-
Syros PharmaceuticalsRecruitingMyelodysplastic SyndromesUnited States, Spain, Belgium, Israel, France, United Kingdom, Austria, Czechia, Italy, Poland, Canada, Hungary, Germany
-
Bristol-Myers SquibbRecruitingMyelodysplastic SyndromesSpain, United States, France, Italy, Belgium, Germany, Poland, Czechia, Puerto Rico
-
Gilead SciencesTerminatedMyelodysplastic SyndromesUnited States, Spain, Belgium, Australia, France, Hong Kong, Hungary, Finland, New Zealand, Germany, Netherlands, United Kingdom, Italy, Switzerland, Portugal, Canada, Austria, Czechia, Norway, Poland, Turkey
-
Bristol-Myers SquibbRecruitingMyelodysplastic SyndromesCanada, United States, China, Australia, France, Greece, Hungary, Germany, Italy, Czechia, Poland, Spain, Brazil, Colombia, India, Mexico, Argentina, Puerto Rico
-
CelgeneCompletedMyelodysplastic SyndromeSpain, United Kingdom, Denmark, Germany, France, Greece, Italy, Sweden, Belgium, United States, Luxembourg, Norway
-
CelgeneAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Active, not recruitingMyelodysplastic SyndromesUnited States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Lithuania, Netherlands, Poland, Portugal, Russian Federation, Spain, Sweden, Switzerland, Taiwan, Turke... and more
-
Janssen Research & Development, LLCActive, not recruitingNeoplasms | Myelodysplastic Syndromes | Non-Hodgkin Lymphoma | Solid Tumor, AdultUnited States, Spain, Israel, Germany, Canada
-
Novartis PharmaceuticalsCompletedMyelodysplastic SyndromesChina, Hong Kong, Switzerland, United Kingdom, Italy, Thailand, Bulgaria, Greece, Russian Federation, Canada, Mexico, Australia, Denmark, Malaysia, New Zealand, United States
-
National Cancer Institute (NCI)RecruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Myeloproliferative NeoplasmUnited States, Canada
-
CelgeneCompletedAnemiaUnited States, Belgium, Spain, United Kingdom, Austria, Canada, Germany, Portugal, France, Australia, Israel, Japan, Italy, Czechia, Poland, Turkey